The Pittsburgh Liver Research Center strives to provide its members with meaningful and relevant enrichment programs.
The Seminar series features established liver researchers and clinicians from the University of Pittsburgh and UPMC as well as from other universities and hospitals. Seminars are held one Monday each month.
The Special Interest Group (SIG) Roundtables are designed to exhibit the connection between work within clinics and labs. Clinicians and basic scientists are paired by topic for these sessions, with both presenters having the opportunity to explicate the topic from the perspective of their own work. The goal is to foster translational science, dialogue, and collaboration among the members of the Center. Each SIG meets once every 6 weeks.
FriSC2 is annual advanced training course that trains 16 promising trainees from predominantly under-represented communities in sophisticated technologies for clinically relevant discoveries in cancer. The purpose of the training course if to provide comprehensive training in research strategies and state-of-the-art methods on cellular, molecular, and genetic approaches for advancing cancer research. It is a dynamic course that offers a series of daily lectures on merging concepts, followed by discussions and laboratory research over a week period. Our intention of to give trainees the knowledge of ‘hands-on’ laboratory techniques, career mentoring, and the ethical-legal-societal impact of cancer and stem cell research to greatly enhance their careers in this field. FriSC2 has been created for promising graduate students, post-docs, physician-scientists and other scientists.
Click here for the full Agenda
Please download the applications for the courses at www.pdc.magee.edu or email at frontiers@mwri.magee.edu with any questions. Course tuition will be waived for all applicants.
Theo Heller, MD
Section Chief: Translational Hepatology Section, Liver Diseases Branch
Senior Investigator: Clinical Research Section, Liver Diseases Branch
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Title: “The dark side of the moon, exploring hepatitis C and liver disease”
Mo Ebrahimkhani, MD
Associate Professor of Pathology
University of Pittsburgh
Title: “Directed Morphogenesis of Multilineage Human Liver Organoids from Pluripotency”
Courtney Sparacino-Watkins, PhD
Research Assistant Professor
Department of Medicine
University of Pittsburgh
Title: TBD
Lans Taylor, PhD
Allegheny Foundation Professor of Computational and Systems Biology
Director, University of Pittsburgh Drug Discovery Institute
Team Leader, Tumorigenesis SIG
University of Pittsburgh
Title: TBD
Natalia Nieto, Pharm.D, M.Sc., Ph.D.
Professor of Pathology
University of Illinois at Chicago
Title: TBD
The Pittsburgh Liver Research Center will be hosting it’s PLRC Annual Retreat this fall at the University Club. We are excited to share that our keynote speaker will be Dr. Sonya MacParland. Dr. MacParland is a Scientist at the Toronto General Research Institute, and Assistant Professor at the University of Toronto in the Departments of Immunology, and Laboratory Medicine & Pathobiology. She is also the Course Director of the UHN/U of T Training Program in Regenerative Medicine. Dr. MacParland has done seminal work in single cell mapping of the human liver with emphasis on immune cells. More information on the retreat will be forthcoming and an RSVP will be sent out via email.
“The 2021 Gordon Research Seminar on Alcohol-Induced End Organ Diseases is an excellent opportunity for trainees in labs studying alcohol-associated injury spanning in experience from early graduate students to senior post-docs to meet and build a future network of peers.”
Angela Gronenborn, PhD
UPMC Rosalind Franklin Professor and Chair
Department of Structural Biology
Distinguished Professor of Structural Biology
University of Pittsburgh School of Medicine
Professor of Bioengineering
Swanson School of Engineering
Title: TBD
The 2021 EASL-AASLD Masterclass provides a unique educational collaboration of clinical, basic, and translational scientists from leading academic medical institutions from both sides of the Atlantic. Participants will attend a two-day intensive training session designed for future leaders in academic hepatology. The program will consist of academic lectures, interactive break-out sessions, individual meetings with tutors, abstract presentations and a poster session, and social events to give early-stage investigators (MD, PhD, or MD/PhD, or equivalent) the opportunity to network with world leaders in hepatology.
This year’s program is hosted by AASLD and will be held in the U.S.A.
For more information, Click here.
